. 2025 Feb 19;15(2):99996. doi: 10.5498/wjp.v15.i2.99996

Table 3.

Association of the number of high-level stress-sensitivity factors with clinical manifestations and follow-up outcomes in major depressive disorders

Items	Time	All factors Partial eta-squared (η²)	Sig.	PSS + S-AI Partial eta-squared (η²)	Sig.	Neuroticism + T-AI partial eta-squared (η²)	Sig.
HAMD-17	Baseline	0.158	< 0.001^a	0.153	< 0.001^a	0.085	< 0.001^a
HAMD-17	At the end of follow-up	NA	NA	NA	NA	0.204	< 0.001^a
HAMA	Baseline	0.145	< 0.001^a	0.129	< 0.001^a	0.072	< 0.001^a
HAMA	At the end of follow-up	NA	NA	NA	NA	0.155	< 0.001^a
BSSI	Baseline	0.160	< 0.001^a	0.117	< 0.001^a	0.135	< 0.001^a
BSSI	At the end of follow-up (n = 66)	NA	NA	NA	NA	0.156	0.002^a
SDS	Baseline	0.240	< 0.001^a	0.132	< 0.001^a	0.145	< 0.001^a
SDS	At the end of follow-up	NA	NA	NA	NA	0.072	0.003^a
PDQ-5	Baseline	0.138	< 0.001^a	0.065	< 0.001^a	0.066	< 0.001^a
PDQ-5	At the end of follow-up	NA	NA	NA	NA	0.143	< 0.001^a

P < 0.05.

The effect size is classified as small (0.01-0.05), medium (0.06-0.13), and large (≥ 0.14) based on Partial η². HAMD-17: 17-item Hamilton Depression Scale; HAMA: Hamilton Anxiety Scale; BSSI: Beck Scale for Suicide Ideation; SDS: Sheehan Disability Scale; PDQ-5: Perceived Deficits Questionnaire five-item version; NA: Not available.